February 2023

Editorial Board
Published in issue: February 2023
i-ii

Editorial

The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease
• Konstantinos H. Katsanos,
• Fotios S. Fousekis,
• Alessandro Armuzzi
Published online: October 29, 2022
p149-150

Viewpoint

Gorilla in the room: Even experts can miss polyps at colonoscopy and how AI helps complex visual perception tasks
• Andrea Cherubini,
• James E. East
Published online: October 26, 2022
p151-153

DLD and the COVID-19 Pandemic

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
• Fabio Salvatore Macaluso,
• Mariabeatrice Principi,
• Federica Facciotti,
• ...
• Giuseppe Rizzo,
• Ambrogio Orlando
• Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
Published online: August 28, 2022
p154-159

Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
• Massimo Iavarone,
• Giulia Tosetti,
• Floriana Facchetti,
• ...
• Luigia Scudeller,
• Antonio Bertoletti,
• Pietro Lampertico
Published online: October 17, 2022
p160-168

Review Articles

Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges
• Jiang Xin
Published online: August 21, 2022
p169-177

Vascular liver diseases: A sex-oriented analysis of the literature
• Alberto Zanetto,
• Valentina Cossiga,
• Sarah Shalaby,
• ...
• Pierluigi Toniutto,
• Patrizia Burra
• on behalf of the Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF)
Published online: July 26, 2022
p178-186

Guidelines

Italian guidelines for the management of irritable bowel syndrome
Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP)
• Giovanni Barbara,
• Cesare Cremon,
• Massimo Bellini,
• ...
• Rocco Maurizio Zagari,
• Letizia Zenzeri,
• Giovanni Marasco
Published online: December 11, 2022
p187-207

Meta-Analysis

Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials
• Pierfrancesco Visaggi,
• Matteo Ghisa,
• Brigida Barberio,
• ...
• Alexander C. Ford,
• Nicola de Bortoli,
• Edoardo Savarino
Published online: May 30, 2022
p208-222

Original Articles

Alimentary Tract


Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease - a retrospective study
• Moran Livne-Margolin,
• Daniel Ling,
• Shani Attia-Konyo,
• ...
• Bella Ungar,
• Shomron Ben-Horin,
• Uri Kopylov
Published online: October 11, 2022
p223-229

Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease
• Laura Melotti,
• Nikolas Konstantine Dussias,
• Marco Salice,
• ...
• Elena Mazzotta,
• Paolo Gionchetti,
• Fernando Rizzello
Published online: July 22, 2022
p230-234

Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade
• Luca Elli,
• Pietro Soru,
• Leda Roncoroni,
• ...
• Sabrina Fabiano,
• Luisa Doneda,
• Maurizio Vecchi
Published online: September 09, 2022
p235-242

Liver, Pancreas and Biliary Tract


Detection of potential pathogen in pancreatic fluid aspiration with metagenomic next-generation sequencing in patients with suspected infected pancreatic necrosis
• Donghuang Hong,
• Peng Wang,
• Yingjie Chen,
• ...
• Zhihui Tong,
• Weiqin Li,
• Lu Ke
Published online: August 07, 2022
p243-248
Indocyanine green (ICG) fluorescent cholangiography in laparoscopic cholecystectomy: Simplifying time and dose
• Fernando Pardo Aranda,
• Clara Gené Škrabec,
• Jaime López-Sánchez,
• ...
• Christian Herrero Vicente,
• Laura Vidal Piñeiro,
• Esteban Cugat Andorrà
Published online: November 18, 2022
p249-253

Sensitivity to thyroid hormones is associated with advanced fibrosis in euthyroid patients with non-alcoholic fatty liver disease: A cross-sectional study
• Ruifang Li,
• Li Zhou,
• Chen Chen,
• ...
• Min Gao,
• Xiaojing Cheng,
• Jia Li
Published online: July 16, 2022
p254-261
Open Access

Digestive Endoscopy


Comparison of assessment tools in acute upper gastrointestinal bleeding: Which one at which time point?
• Riccardo Marmo,
• Marco Soncini,
• Cristina Bucci,
• Angelo Zullo
• on behalf of the GISED
Published online: December 06, 2022
p262-267

Oncology


Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation
• Roberto Rossotti,
• Marco Merli,
• Chiara Mazzarelli,
• ...
• Luca Saverio Belli,
• Luciano Gregorio De Carlis,
• Massimo Puoti
Published online: May 27, 2022
p268-275

Impact of mismatch repair deficiency on tumour regression grade after neoadjuvant chemotherapy in localized gastroesophageal adenocarcinoma
• Maximilien Heran,
• Florence Renaud,
• Christophe Louvet,
• ...
• Thierry André,
• Magali Svrcek,
• Romain Cohen
Published online: June 29, 2022
p276-282

MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma
• Somaia Shehab-Eldeen,
• Mohamed F. Metwaly,
• Safa M. Saber,
• Salah M. El-Kousy,
• Eman A.E. Badr,
• Abdallah Essa
Published online: May 05, 2022
p283-290

Images of the Month

A case of jejunal hemolymphangioma
• Jin Xu,
• Cuiwei Zhang,
• Chuankang Tang
Published online: November 23, 2022
p291-293

Pneumatosis cystoides coli associated with intestinal spirochetosis
• Kenji Yamazaki,
• Ryoji Kushima,
• Noritaka Ozawa,
• Masahito Shimizu
Published online: October 31, 2022
p294-295

Giant gastric myxoid epithelioid gastrointestinal stromal tumor
• Zonglin Li,
• Yejiang Zhou,
• Yifan Jiang,
• Yi Liu
Published online: November 12, 2022
p296-297

Correspondence

More evidence is needed on the additional efficacy of vedolizumab as a first-line biologic therapy for inflammatory bowel disease
• Toshihiko Kakiuchi,
• Masato Yoshiura
Published online: November 19, 2022
p298-299
Reply to comment on: “Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis”
• Mohamed Attauabi,
• Jakob Benedict Seidelin,
• Johan Burisch
Published online: December 01, 2022
p300-301
MiR-21: A potential new target in the treatment strategy of Crohn's disease?
• Yi Zhao,
• Ning Xu,
• Wenying Jiang
Published online: November 18, 2022
p302

Corrigendum

Corrigendum to “Risk of bacterial pneumonia and pneumococcal infection in youths with celiac disease — A population-based study” [Dig Liver Dis 51 (2019) 1101–1105]
• Cristina Canova,
• Jonas F. Ludvigsson,
• Vincenzo Baldo,
• Claudio Barbiellini Amidei,
• Loris Zanier,
• Fabiana Zingone
Published online: December 06, 2022
p303